Intra- and intercellular signaling pathways associated with drug-induced cardiac pathophysiology.

Trends in Pharmacological Sciences
Fei GuoAmy Pointon

Abstract

Cardiac physiology and homeostasis are maintained by the interaction of multiple cell types, via both intra- and intercellular signaling pathways. Perturbations in these signaling pathways induced by oncology therapies can reduce cardiac function, ultimately leading to heart failure. As cancer survival increases, related cardiovascular complications are becoming increasingly prevalent, thus identifying the perturbations and cell signaling drivers of cardiotoxicity is increasingly important. Here, we discuss the homotypic and heterotypic cellular interactions that form the basis of intra- and intercellular cardiac signaling pathways, and how oncological agents disrupt these pathways, leading to heart failure. We also highlight the emerging systems biology techniques that can be applied, enabling a deeper understanding of the intra- and intercellular signaling pathways across multiple cell types associated with cardiovascular toxicity.

References

May 4, 2002·Nature Reviews. Molecular Cell Biology·James J TomasekRobert A Brown
Oct 2, 2002·European Journal of Biochemistry·Nduna Dzimiri
Dec 10, 2002·Science·G ManningS Sudarsanam
Oct 16, 2004·Cardiovascular Research·Peter Kohl
Sep 16, 2005·Heart·Caroline P D Wheeler-Jones
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sandrine FaivreEric Raymond
Dec 13, 2005·Biochimica Et Biophysica Acta·Matthew B Wolf, John W Baynes
Jan 13, 2006·Nature Clinical Practice. Oncology·Rakesh K JainJay S Loeffler
Feb 8, 2006·Annual Review of Physiology·Patrick C H HsiehRichard T Lee
Feb 18, 2006·Circulation Research·Michele MiragoliStephan Rohr
Jul 28, 2006·American Journal of Physiology. Cell Physiology·Puja K Mehta, Kathy K Griendling
Aug 29, 2006·Nature Reviews. Molecular Cell Biology·Joerg Heineke, Jeffery D Molkentin
Nov 18, 2006·Cardiovascular Research·Marcin Bujak, Nikolaos G Frangogiannis
Feb 3, 2007·Current Vascular Pharmacology·Ali BouallegueAshok K Srivastava
Jul 7, 2007·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·S S M RensenG J J M van Eys
Mar 28, 2008·The New England Journal of Medicine·Joseph A Hill, Eric N Olson
Feb 24, 2009·Trends in Cardiovascular Medicine·Anita SchorlemmerRalph V Shohet
Mar 21, 2009·Journal of Cellular and Molecular Medicine·Kathrin RychliJohann Wojta
Aug 25, 2009·Journal of Cardiovascular Pharmacology·Geoffrey G HeskethGordon F Tomaselli
Dec 2, 2009·Nature Reviews. Cardiology·Susanne W M van den BorneJagat Narula
Sep 2, 2010·Circulation·Daniela TirziuMichael Simons
Sep 16, 2010·Nature Reviews. Cardiology·Michael S Ewer, Steven M Ewer
Feb 11, 2011·British Journal of Pharmacology·Hg LavertyJp Valentin
Dec 1, 2012·Nature Reviews. Drug Discovery·Joanne BowesSteven Whitebread
Oct 22, 2013·Journal of Molecular and Cellular Cardiology·Catherine M Howard, Troy A Baudino
Dec 26, 2013·Drug Discovery Today·Jorrit J HornbergTomas Mow
Jan 3, 2014·The Journal of Clinical Investigation·Yoshihiko IchikawaHossein Ardehali
Mar 1, 2014·Circulation Research·Ai-Hsien LiRicardo A Garcia
Apr 10, 2014·Cardiovascular Research·Emilio HirschThomas Thum
Jan 7, 2015·Cardiovascular Research·James E CartledgeCesare M Terracciano
May 13, 2015·Nature Reviews. Cardiology·Michael S Ewer, Steven M Ewer
Jun 16, 2015·Cell·Olaf BergmannJonas Frisén
Jul 17, 2015·JAMA Oncology·UNKNOWN Global Burden of Disease Cancer CollaborationMohsen Naghavi
Sep 16, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Javid J Moslehi, Michael Deininger
Oct 3, 2015·Advanced Drug Delivery Reviews·Anurag MathurKevin E Healy
Nov 26, 2015·Journal of Molecular and Cellular Cardiology·Maarten HulsmansMatthias Nahrendorf
Dec 5, 2015·Circulation Research·Alexander R PintoMichelle D Tallquist

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.